Q8K3Y6 (ZCCHV_RAT) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 65.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Zinc finger CCCH-type antiviral protein 1 Alternative name(s): ADP-ribosyltransferase diphtheria toxin-like 13 Short name=ARTD13 Zinc finger antiviral protein Short name=ZAP Short name=rZAP | ||||
| Gene names |
| ||||
| Organism | Rattus norvegicus (Rat) [Reference proteome] | ||||
| Taxonomic identifier | 10116 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Rattus![]() |
Protein attributes
| Sequence length | 776 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Antiviral protein which inhibits the replication of viruses by recruiting the cellular RNA degradation machineries to degrade the viral mRNAs. Binds to a ZAP-responsive element (ZRE) present in the target viral mRNA, recruits cellular poly(A)-specific ribonuclease PARN to remove the poly(A) tail, and the 3'-5' exoribonuclease complex exosome to degrade the RNA body from the 3'-end. It also recruits the decapping complex DCP1-DCP2 through RNA helicase p72 (DDX17) to remove the cap structure of the viral mRNA to initiate its degradation from the 5'-end. Its target viruses belong to families which include retroviridae: human immunodeficiency virus type 1 (HIV-1) and moloney and murine leukemia virus (MoMLV), filoviridae: ebola virus (EBOV) and marburg virus (MARV), togaviridae: sindbis virus (SINV) and Ross river virus (RRV). Specifically targets the multiply spliced but not unspliced or singly spliced HIV-1 mRNAs for degradation. Ref.1 Ref.3 Ref.6 Ref.7 Ref.8 Ref.9 Ref.13 |
| Subunit structure | Homodimer or homooligomer. Homooligomerization is essential for its antiviral activity. Interacts with EXOSC5. Interacts with EXOSC3, EXOSC7, DCP2 and DCP1A By similarity. Interacts with PARN in an RNA-independent manner By similarity. Interacts with XRN1 in an RNA-dependent manner By similarity. Interacts (via N-terminal domain) with DHX30 (via N-terminus) in an RNA-independent manner. Interacts (via N-terminal domain) with DDX17 in an RNA-independent manner. Ref.7 Ref.10 Ref.11 Ref.12 Ref.13 Ref.15 |
| Subcellular location | Cytoplasm. Nucleus. Note: Localizes in the cytoplasm at steady state, but shuttles between nucleus and cytoplasm in a XPO1-dependent manner. Ref.4 Ref.8 |
| Tissue specificity | Expressed in the kidney and liver. Ref.1 |
| Induction | By type I interferon (IFN) and viruses. Ref.8 |
| Domain | The N-terminal domain is sufficient to bind to viral RNAs and promote their degradation. The second and fourth zinc fingers are involved in binding to specific viral RNAs By similarity. Ref.15 |
| Post-translational modification | Phosphorylation at Ser-274 is essential for sequential phosphorylation of Ser-270, Ser-266, Ser-262 and Ser-257 by GSK3-beta. Phosphorylation by GSK3-beta enhances its antiviral activity. |
| Sequence similarities | Contains 4 C3H1-type zinc fingers. Contains 1 WWE domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 776 | 776 | Zinc finger CCCH-type antiviral protein 1 | PRO_0000211344 | |||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||
| Domain | 671 – 758 | 88 | WWE | ||||||||||||||||||||||||||||||||||||||
| Zinc finger | 73 – 86 | 14 | C3H1-type 1 | ||||||||||||||||||||||||||||||||||||||
| Zinc finger | 88 – 110 | 23 | C3H1-type 2 | ||||||||||||||||||||||||||||||||||||||
| Zinc finger | 150 – 172 | 23 | C3H1-type 3 | ||||||||||||||||||||||||||||||||||||||
| Zinc finger | 169 – 193 | 25 | C3H1-type 4 | ||||||||||||||||||||||||||||||||||||||
| Region | 1 – 254 | 254 | N-terminal domain | ||||||||||||||||||||||||||||||||||||||
| Region | 224 – 254 | 31 | Binding to EXOSC5 | ||||||||||||||||||||||||||||||||||||||
| Motif | 69 – 76 | 8 | Nuclear localization signal Ref.4 | ||||||||||||||||||||||||||||||||||||||
| Motif | 284 – 291 | 8 | Nuclear export signal | ||||||||||||||||||||||||||||||||||||||
| Motif | 405 – 406 | 2 | Nuclear localization signal Potential | ||||||||||||||||||||||||||||||||||||||
| Compositional bias | 343 – 348 | 6 | Poly-Ser | ||||||||||||||||||||||||||||||||||||||
| Compositional bias | 415 – 418 | 4 | Poly-Leu | ||||||||||||||||||||||||||||||||||||||
| Compositional bias | 533 – 536 | 4 | Poly-Ser | ||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||
| Modified residue | 257 | 1 | Phosphoserine; by GSK3-beta Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 262 | 1 | Phosphoserine; by GSK3-beta Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 266 | 1 | Phosphoserine; by GSK3-beta Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 270 | 1 | Phosphoserine; by GSK3-beta Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 274 | 1 | Phosphoserine Ref.14 | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 283 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 325 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 351 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 398 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 501 | 1 | Phosphotyrosine By similarity | ||||||||||||||||||||||||||||||||||||||
| Modified residue | 544 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 88 | 1 | C → R: Results in a non-functional protein with a dominant negative phenotype. Ref.11 | ||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||
| Helix | 9 – 16 | 8 | |||||||||||||||||||||||||||||||||||||||
| Turn | 17 – 19 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 20 – 22 | 3 | |||||||||||||||||||||||||||||||||||||||
| Helix | 23 – 30 | 8 | |||||||||||||||||||||||||||||||||||||||
| Helix | 34 – 44 | 11 | |||||||||||||||||||||||||||||||||||||||
| Turn | 46 – 48 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 49 – 53 | 5 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 62 – 66 | 5 | |||||||||||||||||||||||||||||||||||||||
| Helix | 89 – 92 | 4 | |||||||||||||||||||||||||||||||||||||||
| Helix | 97 – 99 | 3 | |||||||||||||||||||||||||||||||||||||||
| Helix | 115 – 123 | 9 | |||||||||||||||||||||||||||||||||||||||
| Helix | 131 – 139 | 9 | |||||||||||||||||||||||||||||||||||||||
| Helix | 143 – 145 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 156 – 158 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 163 – 166 | 4 | |||||||||||||||||||||||||||||||||||||||
| Helix | 175 – 178 | 4 | |||||||||||||||||||||||||||||||||||||||
| Helix | 196 – 205 | 10 | |||||||||||||||||||||||||||||||||||||||
| Helix | 209 – 223 | 15 | |||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein." Gao G., Guo X., Goff S.P. Science 297:1703-1706(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY. |
| [2] | Lubec G., Kang S.U., Lubec S. Submitted (SEP-2007) to UniProtKB Cited for: PROTEIN SEQUENCE OF 227-238; 341-349; 359-371 AND 548-562, MASS SPECTROMETRY. Strain: Sprague-Dawley. Tissue: Brain. |
| [3] | "Expression of the zinc-finger antiviral protein inhibits alphavirus replication." Bick M.J., Carroll J.W., Gao G., Goff S.P., Rice C.M., McDonald M.R. J. Virol. 77:11555-11562(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [4] | "ZAP is a CRM1-dependent nucleocytoplasmic shuttling protein." Liu L., Chen G., Ji X., Gao G. Biochem. Biophys. Res. Commun. 321:517-523(2004) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, NUCLEAR LOCALIZATION SIGNAL, NUCLEAR EXPORT SIGNAL. |
| [5] | "The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs." Guo X., Carroll J.-W., McDonald M.R., Goff S.P., Gao G. J. Virol. 78:12781-12787(2004) [PubMed] [Europe PMC] [Abstract] Cited for: RNA-BINDING. |
| [6] | "Inhibition of filovirus replication by the zinc finger antiviral protein." Mueller S., Moeller P., Bick M.J., Wurr S., Becker S., Guenther S., Kuemmerer B.M. J. Virol. 81:2391-2400(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [7] | "The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA." Guo X., Ma J., Sun J., Gao G. Proc. Natl. Acad. Sci. U.S.A. 104:151-156(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH EXOSC5. |
| [8] | "The zinc finger antiviral protein acts synergistically with an interferon-induced factor for maximal activity against alphaviruses." MacDonald M.R., Machlin E.S., Albin O.R., Levy D.E. J. Virol. 81:13509-13518(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INDUCTION, SUBCELLULAR LOCATION. |
| [9] | "Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein." Kerns J.A., Emerman M., Malik H.S. PLoS Genet. 4:E21-E21(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [10] | "p72 DEAD box RNA helicase is required for optimal function of the zinc-finger antiviral protein." Chen G., Guo X., Lv F., Xu Y., Gao G. Proc. Natl. Acad. Sci. U.S.A. 105:4352-4357(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DDX17. |
| [11] | "Identification of a dominant negative inhibitor of human zinc finger antiviral protein reveals a functional endogenous pool and critical homotypic interactions." Law L.M., Albin O.R., Carroll J.W., Jones C.T., Rice C.M., Macdonald M.R. J. Virol. 84:4504-4512(2010) [PubMed] [Europe PMC] [Abstract] Cited for: SUBUNIT, MUTAGENESIS OF CYS-88. |
| [12] | "DEXH-Box protein DHX30 is required for optimal function of the zinc-finger antiviral protein." Ye P., Liu S., Zhu Y., Chen G., Gao G. Protein Cell 1:956-964(2010) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DHX30. |
| [13] | "Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation." Zhu Y., Chen G., Lv F., Wang X., Ji X., Xu Y., Sun J., Wu L., Zheng Y.T., Gao G. Proc. Natl. Acad. Sci. U.S.A. 108:15834-15839(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH EXOSC5. |
| [14] | "Glycogen synthase kinase 3? (GSK3?) modulates antiviral activity of zinc-finger antiviral protein (ZAP)." Sun L., Lv F., Guo X., Gao G. J. Biol. Chem. 287:22882-22888(2012) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-257; SER-262; SER-266; SER-270 AND SER-274. |
| [15] | "Structure of N-terminal domain of ZAP indicates how a zinc-finger protein recognizes complex RNA." Chen S., Xu Y., Zhang K., Wang X., Sun J., Gao G., Liu Y. Nat. Struct. Mol. Biol. 19:430-435(2012) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-225, SUBUNIT, RNA-BINDING, DOMAIN N-TERMINAL. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF521008 mRNA. Translation: AAM75358.1. | ||||||||||||
| IPI | IPI00202734. | ||||||||||||
| UniGene | Rn.42053. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q8K3Y6. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-29842N. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q8K3Y6. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q8K3Y6. | ||||||||||||
| PRIDE | Q8K3Y6. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| UCSC | RGD:628694. rat. | ||||||||||||
Organism-specific databases | |||||||||||||
| RGD | 628694. Zc3hav1. | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG83866. | ||||||||||||
| HOGENOM | HOG000236279. | ||||||||||||
| HOVERGEN | HBG050384. | ||||||||||||
| InParanoid | Q8K3Y6. | ||||||||||||
| OrthoDB | EOG4HHP1P. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q8K3Y6. | ||||||||||||
| Genevestigator | Q8K3Y6. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR004170. WWE-dom. IPR000571. Znf_CCCH. [Graphical view] | ||||||||||||
| PROSITE | PS50918. WWE. 1 hit. PS50103. ZF_C3H1. 2 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Entry information
| Entry name | ZCCHV_RAT | ||||||||
| Accession | Primary (citable) accession number: Q8K3Y6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
